Clinical trial recruitment stands at the forefront of drug and medical device development for companies, yet it often ...
Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for people with cancer, today announced ...
Clark, Executive Director, Patient Innovation & Engagement, Global Medical and Scientific Affairs at Merck, about the ...
Phase 2 trial is an adaptive designed randomized study comparing NGC-Cap to monotherapy capecitabineResults from this Phase 2 trial will evaluate ...
The U.S. Securities and Exchange Commission said on Thursday that it charged Cassava Sciences and two of the company's former ...
The addition of the cancer immunotherapy drug atezolizumab to the standard of care concurrent chemoradiation (cCRT) did not ...
Aiming to expedite drug development, enhance the body of clinical evidence supporting new and existing therapies, and improve ...
This partnership is poised to revolutionize clinical insights and decision-making for the pharma industry with the aim of ...
Researchers from Stanford University and Rensselaer Polytechnic Institute have developed an advanced AI model that improves ...
ProJenX teamed with Unlearn to create digital twins of ALS patients as a placebo group in open-label extension of Phase 1 ...
The Pediatric Clinical Trials Office at Children’s of Alabama is helping lead the way in finding the best treatments for ...
Car-T cell therapy has changed the face of many cancer treatments, but the level of customization it requires still comes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback